{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:22:39Z","timestamp":1771456959758,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10096-024-04784-0","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T10:05:15Z","timestamp":1708337115000},"page":"767-775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk factors and outcome associated with the acquisition of MDR linezolid-resistant Enterococcus faecium: a report from tertiary care centre"],"prefix":"10.1007","volume":"43","author":[{"given":"Vandana","family":"Rani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Kitoi","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rushika","family":"Saksena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailash Chandra","family":"Dabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin-ul","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Gaind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"issue":"8","key":"4784_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/microorganisms8081118","volume":"8","author":"S Ramos","year":"2020","unstructured":"Ramos S, Silva V, Dapkevicius MLE, Igrejas G, Poeta P (2020) Enterococci, from harmless bacteria to a pathogen. Microorganisms 8(8):1118","journal-title":"Microorganisms"},{"issue":"1","key":"4784_CR2","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1038\/s41598-020-61002-5","volume":"10","author":"R Zaheer","year":"2020","unstructured":"Zaheer R, Cook SR, Barbieri R, Goji N, Cameron A, Petkau A, Polo RO, Tymensen L, Stamm C, Song J, Hannon S, Jones T, Church D, Booker CW, Amoako K, Van Domselaar G, Read RR, McAllister TA (2020) Surveillance of Enterococcus spp. reveals distinct species and antimicrobial resistance diversity across a One-Health continuum. Sci Rep 10(1):3937","journal-title":"Sci Rep"},{"key":"4784_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jgar.2020.01.010","volume":"21","author":"E Rodr\u00edguez-Noriega","year":"2020","unstructured":"Rodr\u00edguez-Noriega E, Hern\u00e1ndez-Morfin N, Garza-Gonzalez E, Bocanegra-Ibarias P, Flores-Trevi\u00f1o S, Esparza-Ahumada S et al (2020) Risk factors and outcome associated with the acquisition of linezolid-resistant Enterococcus faecalis. J Glob Antimicrob Resist 21:405\u2013409","journal-title":"J Glob Antimicrob Resist"},{"issue":"47","key":"4784_CR4","doi-asserted-by":"publisher","first-page":"19046","DOI":"10.2807\/ese.13.47.19046-en","volume":"13","author":"G Werner","year":"2008","unstructured":"Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A et al (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Eurosurveillance 13(47):19046","journal-title":"Eurosurveillance"},{"key":"4784_CR5","doi-asserted-by":"publisher","first-page":"16959","DOI":"10.3402\/iee.v2i0.16959","volume":"2","author":"O Nilsson","year":"2012","unstructured":"Nilsson O (2012) Vancomycin resistant enterococci in farm animals - occurrence and importance. Infect Ecol Epidemiology 2:16959. https:\/\/doi.org\/10.3402\/iee.v2i0.16959","journal-title":"Infect Ecol Epidemiology"},{"issue":"1","key":"4784_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/mdr.2017.0049","volume":"24","author":"A Jahansepas","year":"2018","unstructured":"Jahansepas A, Aghazadeh M, Rezaee MA, Hasani A, Sharifi Y, Aghazadeh T, Mardaneh J (2018) Occurrence of Enterococcus faecalis and Enterococcus faecium in various clinical infections: detection of their drug resistance and virulence determinants. Microbial Drug Resist (Larchmont, N.Y.) 24(1):76\u201382","journal-title":"Microbial Drug Resist (Larchmont, N.Y.)"},{"issue":"8","key":"4784_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2217\/fmb.13.66","volume":"8","author":"AP Hendrickx","year":"2013","unstructured":"Hendrickx AP, van Schaik W, Willems RJ (2013) The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis. Future Microbiol 8(8):993\u20131010","journal-title":"Future Microbiol"},{"issue":"3","key":"4784_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.15537\/smj.2016.3.13871","volume":"37","author":"TA El-Kersh","year":"2016","unstructured":"El-Kersh TA, Marie MA, Al-Sheikh YA, Al-Agamy MH, Al Bloushy AA (2016) Prevalence and risk factors of early fecal carriage of Enterococcus faecalis and Staphylococcus spp and their antimicrobial resistant patterns among healthy neonates born in a hospital setting in central Saudi Arabia. Saudi Med J 37(3):280\u2013287","journal-title":"Saudi Med J"},{"key":"4784_CR9","volume-title":"Enterococci: From Commensals to Leading Causes of Drug Resistant Infection","author":"NI Agudelo Higuita","year":"2014","unstructured":"Agudelo Higuita NI, Huycke MM (2014) Enterococcal disease, epidemiology, and implications for treatment. In M. S. Gilmore (Eds.) et. al., Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. Massachusetts Eye and Ear Infirmary."},{"issue":"1","key":"4784_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1080\/22221751.2020.1769500","volume":"9","author":"O Ayobami","year":"2020","unstructured":"Ayobami O, Willrich N, Reuss A, Eckmanns T, Markwart R (2020) The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerg Microbes Infect 9(1):1180\u20131193","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"4784_CR11","first-page":"286","volume":"11","author":"N Saenhom","year":"2022","unstructured":"Saenhom N, Boueroy P, Chopjitt P, Hatrongjit R, Kerdsin A (2022) Distinguishing clinical Enterococcus faecium strains and resistance to vancomycin using a simple in-house screening test. Antibiotics (Basel, Switzerland) 11(3):286","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"4784_CR12","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2147\/DDDT.S164515","volume":"12","author":"SMR Hashemian","year":"2018","unstructured":"Hashemian SMR, Farhadi T, Ganjparvar M (2018) Linezolid: a review of its properties, function, and use in critical care. Drug Des Devel Ther 12:1759\u20131767","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"4784_CR13","doi-asserted-by":"publisher","first-page":"e0233504","DOI":"10.1371\/journal.pone.0233504","volume":"15","author":"B Krawczyk","year":"2020","unstructured":"Krawczyk B, Wysocka M, Kot\u0142owski R, Bronk M, Michalik M, Samet A (2020) Linezolid-resistant Enterococcus faecium strains isolated from one hospital in Poland\u2013commensals or hospital-adapted pathogens? PLoS One 15(5):e0233504","journal-title":"PLoS One"},{"key":"4784_CR14","volume-title":"In StatPearls","author":"M Levitus","year":"2023","unstructured":"Levitus M, Rewane A, Perera TB (2023) Vancomycin-resistant enterococci. In: In StatPearls. StatPearls Publishing"},{"issue":"7","key":"4784_CR15","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1128\/AAC.45.7.2154-2156.2001","volume":"45","author":"J Prystowsky","year":"2001","unstructured":"Prystowsky J, Siddiqui F, Chosay J, Shinabarger DL, Millichap J, Peterson LR, Noskin GA (2001) Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 45(7):2154\u20132156","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"4784_CR16","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/jac\/dkt092","volume":"68","author":"J Shen","year":"2013","unstructured":"Shen J, Wang Y, Schwarz S (2013) Presence and dissemination of the multiresistance gene cfr in gram-positive and gram-negative bacteria. J Antimicrob Chemother 68(8):1697\u20131706","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"4784_CR17","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1093\/jac\/dkv116","volume":"70","author":"Y Wang","year":"2015","unstructured":"Wang Y, Lv Y, Cai J, Schwarz S, Cui L, Hu Z, Zhang R, Li J, Zhao Q, He T, Wang D, Wang Z, Shen Y, Li Y, Fe\u00dfler AT, Wu C, Yu H, Deng X, Xia X, Shen J (2015) A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin. J Antimicrob Chemother 70(8):2182\u20132190","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"4784_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1086\/344177","volume":"35","author":"MP Pai","year":"2002","unstructured":"Pai MP, Rodvold KA, Schreckenberger PC, Gonzales RD, Petrolatti JM, Quinn JP (2002) Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium. Clin Infect Dis 35(10):1269\u20131272","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4784_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3201\/eid1307.070019","volume":"13","author":"MA Kainer","year":"2007","unstructured":"Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S et al (2007) Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis 13(7):1024","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"4784_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.diagmicrobio.2018.01.027","volume":"91","author":"TT Smith","year":"2018","unstructured":"Smith TT, Tamma PD, Do TB, Dzintars KE, Zhao Y, Cosgrove SE, Avdic E (2018) Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium. Diagn Microbiol Infect Dis 91(2):161\u2013163","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"4784_CR21","doi-asserted-by":"publisher","first-page":"ofy185","DOI":"10.1093\/ofid\/ofy185","volume":"5","author":"MH Greene","year":"2018","unstructured":"Greene MH, Harris BD, Nesbitt WJ, Watson ML, Wright PW, Talbot TR, Nelson GE (2018) Risk factors and outcomes associated with acquisition of daptomycin and linezolid-nonsusceptible vancomycin-resistant Enterococcus. Open Forum Infect Dis 5(10):ofy185","journal-title":"Open Forum Infect Dis"},{"key":"4784_CR22","volume-title":"performance Standards for Antimicrobial Susceptibility Testing: 33th informational supplement M100-S30","author":"Clinical and Laboratory Standards Institute","year":"2023","unstructured":"Clinical and Laboratory Standards Institute (2023) performance Standards for Antimicrobial Susceptibility Testing: 33th informational supplement M100-S30. Wayne, Pa, USA"},{"issue":"3","key":"4784_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"4784_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1086\/319600","volume":"32","author":"AD Harris","year":"2001","unstructured":"Harris AD, Karchmer TB, Carmeli Y, Samore MH (2001) Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 32(7):1055\u20131061","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4784_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2307\/30141777","volume":"19","author":"WJ Martone","year":"1998","unstructured":"Martone WJ (1998) Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 19(8):539\u2013545","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"4784_CR26","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1128\/JCM.00211-16","volume":"54","author":"ML Faron","year":"2016","unstructured":"Faron ML, Ledeboer NA, Buchan BW (2016) Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant Enterococcus in the health care setting. J Clin Microbiol 54(10):2436\u20132447","journal-title":"J Clin Microbiol"},{"issue":"9","key":"4784_CR27","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1017\/ice.2018.146","volume":"39","author":"H McDermott","year":"2018","unstructured":"McDermott H, Skally M, O'Rourke J, Humphreys H, Fitzgerald-Hughes D (2018) Near-patient environmental contamination of an intensive care unit with vancomycin-resistant Enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) before and after the introduction of chlorhexidine bathing for patients. Infect Control Hosp Epidemiol 39(9):1131\u20131132","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"4784_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N et al (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318\u2013327","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"4784_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jgar.2015.02.007","volume":"3","author":"I Klare","year":"2015","unstructured":"Klare I, Fleige C, Geringer U, Th\u00fcrmer A, Bender J, Mutters NT et al (2015) Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients. J Glob Antimicrob Resist 3(2):128\u2013131","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"4784_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1128\/AAC.40.4.839","volume":"40","author":"GE Zurenko","year":"1996","unstructured":"Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ (1996) In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother 40(4):839\u2013845","journal-title":"Antimicrob Agents Chemother"},{"key":"4784_CR31","first-page":"118","volume-title":"Program and abstracts of the 39th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco)","author":"G Zurenko","year":"1999","unstructured":"Zurenko G, Todd WM, Hafkin BA, Myers B, Kaufman C, Bock J (1999) Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid [abstract 848]. In: Program and abstracts of the 39th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). American Society for Microbiology, Washington, DC, p 118"},{"issue":"11","key":"4784_CR32","doi-asserted-by":"publisher","first-page":"E146","DOI":"10.1086\/374929","volume":"36","author":"S Rahim","year":"2003","unstructured":"Rahim S, Pillai SK, Gold HS, Venkataraman L, Inglima K, Press RA (2003) Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin Infect Dis 36(11):E146\u2013E148","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4784_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/mdr.2018.0005","volume":"25","author":"B Bai","year":"2019","unstructured":"Bai B, Hu K, Zeng J, Yao W, Li D, Pu Z et al (2019) Linezolid consumption facilitates the development of linezolid resistance in Enterococcus faecalis in a tertiary-care hospital: a 5-year surveillance study. Microb Drug Resist 25(6):791\u2013798","journal-title":"Microb Drug Resist"},{"key":"4784_CR34","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2147\/IDR.S181339","volume":"11","author":"M Chen","year":"2018","unstructured":"Chen M, Pan H, Lou Y, Wu Z, Zhang J, Huang Y, Yu W, Qiu Y (2018) Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis. Infect Drug Resist 11:2397\u20132409","journal-title":"Infect Drug Resist"},{"issue":"9","key":"4784_CR35","doi-asserted-by":"publisher","first-page":"e74734","DOI":"10.1371\/journal.pone.0074734","volume":"8","author":"C Gudiol","year":"2013","unstructured":"Gudiol C, Ayats J, Camoez M, Dom\u00ednguez M\u00c1, Garc\u00eda-Vidal C, Bodro M et al (2013) Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes. PLoS One 8(9):e74734","journal-title":"PLoS One"},{"issue":"2","key":"4784_CR36","doi-asserted-by":"publisher","first-page":"151477","DOI":"10.1016\/j.ijmm.2021.151477","volume":"311","author":"F Olearo","year":"2021","unstructured":"Olearo F, Both A, Campos CB, Hilgarth H, Klupp EM, Hansen JL, Rohde H (2021) Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption. Int J Med Microbiol 311(2):151477","journal-title":"Int J Med Microbiol"},{"issue":"12","key":"4784_CR37","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1086\/523276","volume":"28","author":"JM Pogue","year":"2007","unstructured":"Pogue JM, Paterson DL, Pasculle AW, Potoski BA (2007) Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 28(12):1382\u20131388","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4784_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jgar.2020.03.027","volume":"22","author":"J Zou","year":"2020","unstructured":"Zou J, Xia Y (2020) Molecular characteristics and risk factors associated with linezolid-resistant Enterococcus faecalis infection in Southwest China. J Glob Antimicrob Resist 22:504\u2013510","journal-title":"J Glob Antimicrob Resist"},{"key":"4784_CR39","doi-asserted-by":"crossref","unstructured":"Golob M, Pate M, Ku\u0161ar D, Dermota U, Avber\u0161ek J, Papi\u0107 B, Zdovc I (2019) Antimicrobial resistance and virulence genes in Enterococcus faecium and Enterococcus faecalis from humans and retail red meat. BioMed Res Int 2019","DOI":"10.1155\/2019\/2815279"},{"issue":"12","key":"4784_CR40","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/cid\/ciw173","volume":"62","author":"BS Shukla","year":"2016","unstructured":"Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi J, Munita JM, Hasbun R, Arias CA (2016) Influence of minimum inhibitory concentration in clinical outcomes of Enterococcus faecium bacteremia treated with daptomycin: is it time to change the breakpoint? Clin Infect Dis 62(12):1514\u20131520","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4784_CR41","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.clinthera.2010.09.008","volume":"32","author":"CW Crank","year":"2010","unstructured":"Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J (2010) Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: a retrospective, multicenter, cohort study. Clin Ther 32(10):1713\u20131719","journal-title":"Clin Ther"},{"issue":"9","key":"4784_CR42","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1093\/jac\/dkw179","volume":"71","author":"L Garc\u00eda-Mart\u00ednez","year":"2016","unstructured":"Garc\u00eda-Mart\u00ednez L, Gracia-Ahulfinger I, Machuca I, Cantis\u00e1n S, De La Fuente S, Natera C, P\u00e9rez-Nadales E, Vidal E, Rivero A, Rodr\u00edguez-Lopez F, Del Prado JR, Torre-Cisneros J (2016) Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study. J Antimicrob Chemother 71(9):2606\u20132611","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04784-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T22:02:09Z","timestamp":1711490529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04784-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["4784"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04784-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional ethics committee (IEC\/VMMC\/SJH\/PROJECT\/2020-10\/CC-79).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}